Early ultrasound evaluation for prediction of treatment response to neoadjuvant chemotherapy in triple negative breast cancer patients

被引：0
|
作者：
Adrada, B. E. [1 ]
Candelaria, R. [1 ]
Moulder, S. [1 ]
Lane, D. [1 ]
Santiago, L. [1 ]
Arribas, E. [1 ]
Hess, K. R. [1 ]
Valero, V. [1 ]
Thompson, A. [1 ]
Helgason, T. [1 ]
Ravenberg, E. [1 ]
Yang, W. [1 ]
Rauch, G. M. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-P6-02-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-02-10
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Prediction of pathological complete response to neoadjuvant chemotherapy in early triple negative breast cancer patients by serial breast ultrasound examination
    Rapoport, Bernardo
    Smit, Teresa
    Heyman, Liezl
    Moosa, Farhana
    Benn, Carol Ann
    CANCER RESEARCH, 2021, 81 (04)
  • [2] Response to neoadjuvant chemotherapy in patients with triple negative breast cancer
    Abe, E.
    Hayashi, N.
    Yoshida, A.
    Hamaoka, T.
    Yagata, H.
    Tsugawa, K.
    Tsunoda-Shimizu, H.
    Suzuki, K.
    Nakamura, S.
    CANCER RESEARCH, 2009, 69 (02) : 367S - 367S
  • [3] Evaluation of contrast-enhanced ultrasonography for early prediction of response to neoadjuvant chemotherapy in triple negative breast cancer
    Masumoto, N.
    Kadoya, T.
    Murakami, C.
    Gouda, N.
    Sasada, S.
    Emi, A.
    Haruta, R.
    Kataoka, T.
    Okada, M.
    CANCER RESEARCH, 2017, 77
  • [4] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
  • [5] Deep learning for early prediction of neoadjuvant chemotherapy response in triple negative breast cancers
    Zhou, Zijian
    Elshafeey, Nabil A.
    Rauch, David E.
    Adrada, Beatriz E.
    Candelaria, Rosalind P.
    Guirguis, Mary S.
    Yang, Wei
    Boge, Medine
    Mohamed, Rania M.
    Whitman, Gary J.
    Lane, Deanna L.
    Le-Petross, Huong C.
    Leung, Jessica W. T.
    Santiago, Lumarie
    Scoggins, Marion E.
    Spak, David A.
    Patel, Miral M.
    Perez, Frances
    Tripathy, Debu
    Valero, Vicente
    Yam, Clinton
    Moulder, Stacy
    White, Jason B.
    Son, Jong Bum
    Pagel, Mark D.
    Ma, Jingfei
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Which Imaging Modality Is Superior for Prediction of Response to Neoadjuvant Chemotherapy in Patients with Triple Negative Breast Cancer?
    Atkins, Jordan J.
    Appleton, Catherine M.
    Fisher, Carla S.
    Gao, Feng
    Margenthaler, Julie A.
    JOURNAL OF ONCOLOGY, 2013, 2013
  • [7] Fdg PET/CT early response prediction for triple negative breast cancer neoadjuvant chemotherapy with addition of carboplatin
    Kubeczko, Marcin
    Michalik, Anna
    Badora-Rybicka, Agnieszka
    Polakiewicz-Gilowska, Anna
    d'Amico, Andrea
    Kalemba, Michal
    Lesniak, Aleksandra
    Swiderska, Katarzyna
    Mianowska-Malec, Marta
    Pasierbek, Agnieszka
    Lanoszka, Barbara
    Chomik, Konstanty
    Bobek-Billewicz, Barbara
    Jarzab, Michal
    CANCER RESEARCH, 2022, 82 (04)
  • [8] Monitoring Serum VEGF in Neoadjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer: A New Strategy for Early Prediction of Treatment Response and Patient Survival
    Wang, Ruo-Xi
    Chen, Sheng
    Huang, Liang
    Zhou, Ying
    Shao, Zhi-Ming
    ONCOLOGIST, 2019, 24 (06): : 753 - 761
  • [9] Prediction of early clinical response to neoadjuvant chemotherapy in Triple-negative breast cancer: Incorporating Radiomics through breast MRI
    Lee, Hyo-jae
    Lee, Jeong Hoon
    Lee, Jong Eun
    Na, Yong Min
    Park, Min Ho
    Lee, Ji Shin
    Lim, Hyo Soon
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [10] Early prediction of response to Neoadjuvant Immunotherapy in Triple Negative Breast Cancer (TNBC) with DCEMRI
    Rauch, Gaiane
    Guirguis, Mary
    Patel, Miral
    Candelaria, Rosalind
    Mohamed, Rania
    Moseley, Tanya
    Le-Petross, H. T. Carisa
    Leung, Jessica
    Whitman, Gary
    Lane, Deanna
    Scoggins, Marion
    Perez, Frances
    Sun, Jia
    Pashapoor, Sanaz
    Xu, Zhan
    White, Jason
    Wei, Peng
    Reed, Brandy
    Son, Jong Bum
    Hwang, Ken-Pin
    Panthi, Bikash
    Korkut, Anil
    Huo, Lei
    Hunt, Kelly
    Clayborn, Alyson
    Litton, Jennifer
    Valero, Vicente
    Tripathy, Debu
    Yam, Clinton
    Yang, Wei
    Ma, Jingfei
    Adrada, Beatriz
    CANCER RESEARCH, 2024, 84 (09)
12345